Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: Repeat BCG Vaccinations for the Treatment of Established Type 1 Diabetes [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update examining repeat Bacillus Calmette-Guérin (BCG) vaccinations for established Type 1 diabetes; the study is currently act…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BCG vaccine (Bacillus Calmette-Guérin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Diabetes Mellitus, Type One, Diabetes Mellitus, Type I | Phase 2 | Status: ACTIVE_NOT_RECRUITING